Myocardial KRAS(G12D) expression does not cause cardiomyopathy in mice
- PMID: 24259500
- DOI: 10.1093/cvr/cvt260
Myocardial KRAS(G12D) expression does not cause cardiomyopathy in mice
Abstract
Aims: Germ-line mutations in genes encoding components of the RAS/mitogen-activated protein kinase (MAPK) pathway cause developmental disorders called RASopathies. Hypertrophic cardiomyopathy (HCM) is the most common myocardial pathology and a leading cause of death in RASopathy patients. KRAS mutations are found in Noonan and cardio-facio-cutaneous syndromes. KRAS mutations, unlike mutations of RAF1 and HRAS, are rarely associated with HCM. This has been attributed to the fact that germ-line KRAS mutations cause only a moderate up-regulation of the MAPK pathway. Highly bioactive KRAS mutations have been hypothesized to cause severe cardiomyopathy incompatible with life. The aim of this study was to define the impact of KRAS(G12D) expression in the heart.
Methods and results: To generate mice with endogenous cardiomyocyte-specific KRAS(G12D) expression (cKRAS(G12D) mice), we bred mice with a Cre-inducible allele expressing KRAS(G12D) from its endogenous promoter (Kras2(LSL)) to mice expressing Cre under control of the cardiomyocyte-specific α-myosin heavy chain promoter (αMHC-Cre). cKRAS(G12D) mice showed high levels of myocardial ERK and AKT signalling. However, surprisingly, cKRAS(G12D) mice were born in Mendelian ratios, appeared healthy, and had normal function, size, and histology of the heart.
Conclusion: Mice with cardiomyocyte-specific KRAS(G12D) expression do not develop heart pathology. These results challenge the view that the level of MAPK activation correlates with the severity of HCM in RASopathies and suggests that MAPK-independent strategies may be of interest in the development of new treatments for these syndromes.
Keywords: Cardio-facio-cutaneous syndrome; Cardiomyopathy; KRAS; Noonan syndrome; RASopathies.
Similar articles
-
Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras.J Gastroenterol. 2016 May;51(5):447-57. doi: 10.1007/s00535-015-1121-9. Epub 2015 Sep 11. J Gastroenterol. 2016. PMID: 26361962
-
Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities.Orphanet J Rare Dis. 2016 Jul 22;11(1):101. doi: 10.1186/s13023-016-0479-y. Orphanet J Rare Dis. 2016. PMID: 27450488 Free PMC article.
-
Elevated FBXL6 activates both wild-type KRAS and mutant KRASG12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice.Mil Med Res. 2023 Dec 20;10(1):68. doi: 10.1186/s40779-023-00501-8. Mil Med Res. 2023. PMID: 38124228 Free PMC article.
-
Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.Expert Rev Mol Med. 2008 Dec 9;10:e37. doi: 10.1017/S1462399408000902. Expert Rev Mol Med. 2008. PMID: 19063751 Review.
-
Ras/MAPK syndromes and childhood hemato-oncological diseases.Int J Hematol. 2013 Jan;97(1):30-6. doi: 10.1007/s12185-012-1239-y. Epub 2012 Dec 19. Int J Hematol. 2013. PMID: 23250860 Review.
Cited by
-
Editorial: Molecular pathogenesis and novel treatments for inherited cardiomyopathies.Front Cardiovasc Med. 2023 Sep 6;10:1282852. doi: 10.3389/fcvm.2023.1282852. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37745121 Free PMC article. No abstract available.
-
Pathogenic Mechanisms of Hypertrophic Cardiomyopathy beyond Sarcomere Dysfunction.Int J Mol Sci. 2021 Aug 19;22(16):8933. doi: 10.3390/ijms22168933. Int J Mol Sci. 2021. PMID: 34445638 Free PMC article. Review.
-
Embryonic Expression of NrasG 12 D Leads to Embryonic Lethality and Cardiac Defects.Front Cell Dev Biol. 2021 Feb 11;9:633661. doi: 10.3389/fcell.2021.633661. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33681212 Free PMC article.
-
Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort.Orphanet J Rare Dis. 2019 Feb 7;14(1):29. doi: 10.1186/s13023-019-1010-z. Orphanet J Rare Dis. 2019. PMID: 30732632 Free PMC article.
-
NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.Hum Mol Genet. 2016 May 1;25(9):1703-13. doi: 10.1093/hmg/ddw039. Epub 2016 Feb 16. Hum Mol Genet. 2016. PMID: 26908603 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous